Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Movement Disorders : Official Journal of the Movement Disorder Society|May 27, 2016
A review of disease progression models of Parkinson's disease and applications in clinical trialsCharles S Venuto, Nicholas B Potter, E Ray Dorsey, et al.
Annals of Clinical and Translational Neurology|January 18, 2021
Isradipine plasma pharmacokinetics and exposure-response in early Parkinson's diseaseCharles S Venuto, Luoying Yang, Monica Javidnia, et al.
Antiviral Therapy|November 25, 2017
Inflammation investigated as a source of pharmacokinetic variability of atazanavir in AIDS Clinical Trials Group protocol A5224sCharles S Venuto, Jihoon Lim, Susan Messing, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 12, 2021
Re-Analysis of the STEADY-PD II Trial-Evidence for Slowing the Progression of Parkinson's DiseaseD James Surmeier, Jack T Nguyen, Nicola Lancki, et al.
Plos Currents|May 3, 2011
Advocacy Recruiting for Huntington's Disease Clinical TrialsLavonne Goodman, Cherrie Sia, Roger Carnes, et al.
Pharmacotherapy|November 28, 2025
Constructing a Personalized Treatment Rule for Initial Therapy in Early Parkinson's DiseaseZachary P Brehm, Ruth B Schneider, Charles S Venuto, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 26, 2023
Predicting Ambulatory Capacity in Parkinson's Disease to Analyze Progression, Biomarkers, and Trial DesignCharles S Venuto, Greta Smith, Konnor Herbst, et al.
Therapeutic Drug Monitoring|May 6, 2011
Therapeutic drug monitoring of protease inhibitors and efavirenz in HIV-infected individuals with active substance-related disordersQing Ma, Barry S Zingman, Amneris E Luque, et al.
The Journal of Antimicrobial Chemotherapy|April 4, 2017
Bone mineral density reductions after tenofovir disoproxil fumarate initiation and changes in phosphaturia: a secondary analysis of ACTG A5224sSamir K Gupta, Eunice Yeh, Douglas W Kitch, et al.
The Journal of Antimicrobial Chemotherapy|August 28, 2014
Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS Clinical Trials Group Study A5202Charles S Venuto, Katie Mollan, Qing Ma, et al.
Pageof 4